Biotec Pharmacon

    OverviewSuggest Edit

    Biotec Pharmacon is a biopharmaceutical company that develops and manufactures new immunomodulatory products and cold adapted marine enzymes. The Company focuses on new solutions within wound care, cancer therapies and other immune related disease areas, and aspires to become a supplier of novel enzymes for diagnostics and genetic research.

    TypePublic
    Founded1990
    HQTromsø, NO
    Websitebiotec.no

    Latest Updates

    Employees (est.) (Feb 2019)42(+5%)

    Key People/Management at Biotec Pharmacon

    Christian Jørgensen

    Christian Jørgensen

    CEO
    Rolf Engstad

    Rolf Engstad

    CSO
    Jethro Holter

    Jethro Holter

    Managing Director, ArcticZymes As
    Stuart Devine

    Stuart Devine

    Vice President of Marketing, Woulgan
    Show more

    Biotec Pharmacon Office Locations

    Biotec Pharmacon has an office in Tromsø
    Tromsø, NO (HQ)
    Sykehusveien 23
    Show all (1)

    Biotec Pharmacon Online and Social Media Presence

    Embed Graph

    Biotec Pharmacon Blogs

    Biotec Pharmacon changes its strategic direction and invites shareholders to an information update presentation

    Tromsø, Norway, 2nd December 2019 – Biotec Pharmacon (OSE: Biotec) has decided to focus its future on the enzymes business and holds an investor update presentation on 10th December. Seek a new owner for the wound care – Woulgan® Drive profitability through the enzymes business (ArcticZymes) Sales a…

    Biotec Pharmacon ASA appoints Dr. Jethro Holter as interim CEO

    (Tromsø/Oslo 23. October 2019) Biotec Pharmacon ASA (OSE: “BIOTEC”) announced today that its Board of Directors has unanimously appointed Dr Jethro Holter as the Company’s interim Chief Executive Officer. Jethro, who currently serves as the Managing Director of ArcticZymes AS, a subsidiary of Biotec…

    ArcticZymes launches Triton FREE version of SAN High Quality

    ArcticZymes is pleased to announce the launch of SAN HQ Triton FREE. The new formulation offers the same advantages as SAN HQ, such as highly effective DNA digestion at high salt conditions, extensive quality control testing and compatibility with SAN HQ ELISA to verify the clearance of the enzyme d…

    Biotec and ArcticZymes featured in the September edition of MedNous

    Biotec Pharmacon and ArcticZymes is featured in the September 2019 edition of MedNous, a publication of Evernow Publishing Ltd. The article introduces you to some of the background and foundation for Biotec Pharmacon, and especially ArcticZymes. The full article can be read here    

    Biotec Pharmacon Frequently Asked Questions

    • When was Biotec Pharmacon founded?

      Biotec Pharmacon was founded in 1990.

    • Who are Biotec Pharmacon key executives?

      Biotec Pharmacon's key executives are Christian Jørgensen, Rolf Engstad and Jethro Holter.

    • How many employees does Biotec Pharmacon have?

      Biotec Pharmacon has 42 employees.

    • Who are Biotec Pharmacon competitors?

      Competitors of Biotec Pharmacon include GBT (Global Blood Therapeutics), Melinta Therapeutics and Seelos Therapeutics.

    • Where is Biotec Pharmacon headquarters?

      Biotec Pharmacon headquarters is located at Sykehusveien 23, Tromsø.

    • Where are Biotec Pharmacon offices?

      Biotec Pharmacon has an office in Tromsø.

    • How many offices does Biotec Pharmacon have?

      Biotec Pharmacon has 1 office.